483
University of Texas Southwestern Medical Center, TheUniversity of Texas Southwestern Medical Center, The – FDA 483, Sep 9, 2019
Record Details
An FDA inspection of the University of Texas Southwestern Medical Center, a PET drug manufacturer in Dallas, revealed three significant observations. The firm was cited for failing to verify and document test procedures for environmental monitoring, lacking established procedures for routine calibration of laboratory equipment, and not properly implementing procedures for equipment suitability and qualification, specifically regarding a smoke study for a laminar flow hood.
- Inspection date
- September 9, 2019
- Product type
- drugs
View Company Profile
ID · 52010238-4ea7-4ba2-bdf9-77076dc1a21a
Other documents for University of Texas Southwestern Medical Center, The
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.